Fabtech Technologies Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 345 Cr.
- Current Price ₹ 280
- High / Low ₹ 470 / 162
- Stock P/E 35.9
- Book Value ₹ 75.8
- Dividend Yield 0.71 %
- ROCE 21.6 %
- ROE 16.5 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 24.9% CAGR over last 5 years
Cons
- The company has delivered a poor sales growth of 10.2% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Part of BSE SME IPO
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 86 | 65 | 107 | 114 | 83 | 139 | 131 | |
| 80 | 64 | 101 | 101 | 75 | 123 | 119 | |
| Operating Profit | 6 | 1 | 6 | 12 | 8 | 16 | 11 |
| OPM % | 7% | 2% | 5% | 11% | 10% | 11% | 9% |
| 1 | 0 | 0 | 0 | 1 | 1 | 2 | |
| Interest | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 6 | 0 | 5 | 11 | 7 | 16 | 12 |
| Tax % | 29% | -52% | 35% | 28% | 28% | 24% | |
| 4 | 1 | 3 | 8 | 5 | 12 | 10 | |
| EPS in Rs | 1,310.00 | 233.33 | 11.49 | 29.07 | 18.88 | 9.77 | 7.81 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 9% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 55% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 15% |
| Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 12 | 12 |
| Reserves | 32 | 32 | 35 | 44 | 49 | 81 | 81 |
| 10 | 7 | 8 | 6 | 5 | 0 | 5 | |
| 21 | 25 | 32 | 23 | 24 | 24 | 18 | |
| Total Liabilities | 66 | 67 | 79 | 75 | 81 | 117 | 117 |
| 3 | 3 | 3 | 3 | 4 | 3 | 3 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 3 | 3 | 3 | 3 | 4 | 28 | 21 |
| 60 | 60 | 72 | 69 | 73 | 86 | 93 | |
| Total Assets | 66 | 67 | 79 | 75 | 81 | 117 | 117 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -9 | 4 | 3 | 8 | 4 | 2 | |
| 2 | -1 | -4 | -3 | -2 | -25 | |
| 7 | -3 | 1 | -4 | -2 | 24 | |
| Net Cash Flow | 1 | -1 | 0 | 1 | 0 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 188 | 236 | 172 | 149 | 203 | 132 |
| Inventory Days | 54 | 85 | 52 | 45 | 82 | 58 |
| Days Payable | 108 | 139 | 96 | 69 | 105 | 67 |
| Cash Conversion Cycle | 134 | 183 | 127 | 124 | 179 | 123 |
| Working Capital Days | 115 | 152 | 94 | 101 | 156 | 128 |
| ROCE % | 2% | 13% | 25% | 15% | 22% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Acquisition
11h - Board approved acquisition of 9.2% in Kelvin for ₹4,65,06,000; stake increases to 60.53%; name change approved.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On January 08, 2026
11h - Board approved name change; acquired additional 9.2% in Kelvin for ₹4,65,06,000, stake now 60.53%.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11h - RTA confirms SEBI Reg.74(5) compliance for quarter ended 31 Dec 2025 (ISIN INE0HSD01011).
-
Outcome Of The Analyst / Investor Meeting Held On December 22, 2025
22 Dec - Dec 22, 2025 virtual group analyst/investor meeting with multiple institutional investors; no UPSI discussed.
-
Intimation Of Receipt Of Purchase Order
19 Dec - Received Rs.330,006,870 purchase order from leading solar PV manufacturer; execution by April 30, 2026.
Annual reports
Concalls
-
Nov 2025Transcript PPT
-
Jun 2025TranscriptPPT
-
Mar 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.